KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Sales (2018 - 2025)

Vir Biotechnology's Return on Sales history spans 8 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 8.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.06%, a 1.0% increase, with the full-year FY2025 number at 0.06%, up 1.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2025 for Vir Biotechnology, up from 6.8% in the prior quarter.
  • Over the last five years, Return on Sales for VIR hit a ceiling of 0.01% in Q3 2021 and a floor of 6.8% in Q3 2025.
  • Historically, Return on Sales has averaged 0.58% across 5 years, with a median of 0.05% in 2023.
  • Biggest five-year swings in Return on Sales: surged 86bps in 2022 and later crashed -590bps in 2025.
  • Tracing VIR's Return on Sales over 5 years: stood at 0.01% in 2021, then crashed by -418bps to 0.02% in 2022, then plummeted by -236bps to 0.07% in 2023, then decreased by -22bps to 0.08% in 2024, then surged by 92bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for VIR at 0.01% in Q4 2025, 6.8% in Q3 2025, and 0.91% in Q2 2025.